Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, New York
- Most recent report
- 10-Q, filed Aug 10, 2026
- Incorporated
- Delaware
- Filings on record
- 668 filings
- On EDGAR
- CIK 1579428
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 46
News 8 of 233
Prospectuses and Registrations 8 of 30
- S-3ASR Automatic shelf registration Nov 3, 2025
- S-8 Registration statement for an employee plan Aug 7, 2025
- S-8 Registration statement for an employee plan Aug 5, 2024
- 424B5 Prospectus supplement for an offering Jun 29, 2023
- 424B5 Prospectus supplement for an offering Jun 28, 2023
- S-8 Registration statement for an employee plan Jun 23, 2023
- S-8 Registration statement for an employee plan May 9, 2023
- S-3ASR Automatic shelf registration Dec 2, 2022
Proxies 8 of 15
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2021
Ownership 8 of 319
- 4 Insider reported a trade Aug 7, 2026
- 144 Notice of a proposed sale of restricted stock Aug 6, 2026
- 144 Notice of a proposed sale of restricted stock Aug 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 27, 2026
- 4 Insider reported a trade Jul 1, 2026
- 144 Notice of a proposed sale of restricted stock Jul 1, 2026
- 4 Insider reported a trade Jun 11, 2026
- 144 Notice of a proposed sale of restricted stock Jun 11, 2026
Other 8 of 25
- ARS Annual report sent to shareholders Apr 24, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- ARS Annual report sent to shareholders Apr 21, 2023
- SEC STAFF LETTER Apr 19, 2021
- SEC STAFF LETTER Mar 22, 2021
- EFFECT Notice that a registration became effective Dec 16, 2016
- CORRESP Reply to SEC staff Dec 15, 2016
Everything here comes from Axsome Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.